271 results
-
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 August-1 September 2017
PRAC, Last updated: 01/09/2017 -
List item
Press release: EMA restricts use of multiple sclerosis medicine Zinbryta
PRAC, Last updated: 07/07/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 July 2017
PRAC, Last updated: 07/07/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 June 2017
PRAC, Last updated: 09/06/2017 -
List item
Press release: PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel
PRAC, Last updated: 09/06/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 May 2017
PRAC, Last updated: 05/05/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 April 2017
PRAC, Last updated: 07/04/2017 -
List item
Press release: EMA concludes safety review of Uptravi
PRAC, Last updated: 07/04/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 March 2017
PRAC, Last updated: 10/03/2017 -
List item
Press release: EMA reviewing cancer medicine docetaxel
PRAC, Last updated: 10/03/2017 -
List item
Press release: PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions, including suspension for some marketing authorisations
PRAC, Last updated: 10/03/2017 -
List item
Press release: EMA reviewing safety of Uptravi for pulmonary arterial hypertension (updated)*
PRAC, Last updated: 14/02/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 February 2017
PRAC, Last updated: 10/02/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9-12 January 2017
PRAC, Last updated: 13/01/2017 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2016
PRAC, Last updated: 02/12/2016 -
List item
Press release: PRAC warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C
PRAC, Last updated: 02/12/2016 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24-27 October 2016
PRAC, Last updated: 28/10/2016 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2016
PRAC, Last updated: 30/09/2016 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August - 2 September 2016
PRAC, Last updated: 02/09/2016 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-8 July 2016
PRAC, Last updated: 08/07/2016 -
List item
Press release: PRAC concludes review of Zydelig and issues updated recommendations for use
PRAC, Last updated: 08/07/2016 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 June 2016
PRAC, Last updated: 10/06/2016 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 May 2016
PRAC, Last updated: 13/05/2016 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 April 2016
PRAC, Last updated: 15/04/2016 -
List item
Press release: Listening to the public's views on the safety of medicines
PRAC, Last updated: 15/04/2016